01 15Accord healthcare
02 10Actavis Inc
03 6Aeon Formulations Private Limited
04 3AiPing Pharmaceutical Inc
05 3Alphapharm PTY Ltd
06 3Annora Pharma
07 3Aristo Pharma GmbH
08 5Aurobindo Pharma Limited
09 2Aurovitas Spain, Sau
10 10Chartwell Pharmaceuticals llc
11 9Cheplapharm Arzneimittel Gmbh
12 2Cinfa
13 3CorePharma, LLC
14 2Eris Lifesciences
15 2Flagship Biotech International Pvt. Ltd
16 2Inventia Healthcare Limited
17 3JAMP PHARMA
18 3Krka
19 3Kusum Healthcare Pvt Ltd
20 3MINT PHARMACEUTICALS INC
21 2MS Pharma
22 7Macleods Pharmaceuticals Limited
23 1Myungmoon Pharm. Co., LTD.
24 2Neopharma
25 2ORIFARM GROUP AS
26 8PHARMOBEDIENT
27 3PURACAP PHARM
28 3Pharmascience Inc.
29 3Prinston
30 2STADA Arzneimittel
31 27Takeda Pharmaceutical
32 12Teva Pharmaceutical Industries
33 5Torrent Pharmaceuticals Limited
34 2Umedica Laboratories
35 2Wanbang Biopharmaceuticals
36 3Zydus Pharmaceuticals
37 8Blank
01 6BILAYERED TABLET
02 1Dispersible Tablet
03 13Film Coated Tablet
04 8SR Tablet
05 2Sustained Release Tablet
06 2TAB
07 23TABLET
08 2TABLET, EXTENDED RELEASE;ORAL
09 3TABLET; ORAL
10 72TABLET;ORAL
11 52Tablet
01 4Approved
02 13Authorized
03 8Cancelled
04 2Commercialized In: India (2004), Nigeria (2010), Ghana (2011), Jamaica (2016); Countries Registered In: India (2004), Jamaica (2012), Ghana (2011), Nigeria (2010)
05 21DISCN
06 2Deregistered
07 15Generic
08 1Generic B.E study
09 2Generic CTD, BE- Available
10 3Marketed
11 7Not Marketed
12 12PRESCRIPTION
13 24Prescription
14 53RX
15 2Registered in India (2004), Jamaica (2012), Ghana (2011), Kenya (2012), Nigeria (2010), Philippines (2010)
16 6Registered in India, Jamaica, Ghana, Kenya, Nigeria, Philippines
17 9Blank
01 3ACH-PIOGLITAZONE
02 1ACTAZONE
03 2ACTOPLUS MET
04 2ACTOPLUS MET XR
05 3ACTOS
06 1AEOMET-G1P
07 1AEOMET-G2P
08 1AEOMET-GC1P
09 1AEOMET-GZ1P
10 1AEOMET-GZ2P
11 1AEOMET-GZ3P
12 9Actos
13 1Aim7 30 XR
14 1Aim7 60 XR
15 2Azucar
16 4Competact
17 2DUETACT
18 3GLUTAZONE
19 3Glidipion
20 1Glubrava
21 1Glyact
22 7Incresync
23 3JAMP PIOGLITAZONE
24 3MINT-PIOGLITAZONE
25 6OSENI
26 3PIOGLITAZONE
27 45PIOGLITAZONE HYDROCHLORIDE
28 2PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
29 12PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
30 1PIOTAZ
31 3PMS-PIOGLITAZONE
32 3Paglitaz
33 3Pioglitazon "Actavis"
34 2Pioglitazona Cinfa
35 4Pioglitazona Teva Pharma
36 6Pioglitazone Accord
37 4Pioglitazone Actavis
38 2Pioglitazone Aurovitas
39 2Pioglitazone Edigent
40 1Pioglitazone Hydrochloride Tablets Macleods 15 mg
41 1Pioglitazone Hydrochloride Tablets Macleods 30 mg
42 3Pioglitazone "Accord"
43 1Pioglitazone/Metformin Aristo
44 2Stada Pioglitazone
45 3TEVA-PIOGLITAZONE
46 2Tandemact
47 16Blank
01 15Canada
02 2China
03 21Denmark
04 23India
05 2Jordan
06 10Norway
07 2South Africa
08 1South Korea
09 21Spain
10 6Sweden
11 2U.A.E
12 77USA
13 2Blank
Regulatory Info :
Registration Country : USA
Brand Name : PIOGLITAZONE
Dosage Form : TABLET; ORAL
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 76799
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PIOGLITAZONE
Dosage Form : TABLET; ORAL
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 76799
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-08-29
Application Number : 21842
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET
Dosage Form : TABLET;ORAL
Dosage Strength : 850MG;EQ 15MG BASE
Packaging :
Approval Date : 2005-08-29
Application Number : 21842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : DUETACT
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG;30MG
Packaging :
Approval Date : 2006-07-28
Application Number : 21925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : DUETACT
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG;30MG
Packaging :
Approval Date : 2006-07-28
Application Number : 21925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM;EQ 15MG BASE
Packaging :
Approval Date : 2009-05-12
Application Number : 22024
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM;EQ 30MG BASE
Packaging :
Approval Date : 2009-05-12
Application Number : 22024
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 15MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 30MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 45MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 30MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : DISCN
Registration Country : USA
